A prospective longitudinal study of Pasireotide in Nelson’s syndrome

Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial

(2018) André Lacroix et al.   Lancet Diabetes & Endocrinology

Characterizing and predicting the Nelson-Salassa syndrome

(2017) Christopher S. Graffeo et al.   JOURNAL OF NEUROSURGERY

The USP8 mutational status may predict drug susceptibility in corticotroph adenomas of Cushing's disease

(2015) K. Hayashi et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

The effects of somatostatin analogue therapy on pituitary tumor volume in patients with acromegaly

(2015) Annamaria Colao et al.   Pituitary

Pasireotide treatment significantly improves clinical signs and symptoms in patients with Cushing's disease: results from a Phase III study

(2014) Rosario Pivonello et al.   CLINICAL ENDOCRINOLOGY

Gamma knife radiosurgery for Cushing’s disease and Nelson’s syndrome

(2014) Josef Marek et al.   Pituitary

Sustained Improvements in Plasma ACTH and Clinical Status in a Patient With Nelson's Syndrome Treated With Pasireotide LAR, a Multireceptor Somatostatin Analog

(2013) Laurence Katznelson   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Hyperglycemia Associated With Pasireotide: Results From a Mechanistic Study in Healthy Volunteers

(2013) Robert R. Henry et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Managing hyperglycemia in patients with Cushing’s disease treated with pasireotide: medical expert recommendations

(2013) Annamaria Colao et al.   Pituitary

A 12-Month Phase 3 Study of Pasireotide in Cushing's Disease

(2012) Annamaria Colao et al.   NEW ENGLAND JOURNAL OF MEDICINE

Pituitary-directed medical therapy with pasireotide for a corticotroph macroadenoma: pituitary volume reduction and literature review

(2012) Ilan Shimon et al.   Pituitary

Pasireotide Alone or with Cabergoline and Ketoconazole in Cushing's Disease

(2010) Richard A. Feelders et al.   NEW ENGLAND JOURNAL OF MEDICINE

Treatment of Nelson's syndrome with temozolomide

(2008) V J Moyes et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY